Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Mar;59(3):381–384. doi: 10.1038/bjc.1989.76

Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.

J M Hughes 1, M H Tattersall 1
PMCID: PMC2247054  PMID: 2930702

Abstract

Modulation of nucleic acid antimetabolite cytotoxicity by preformed purines and pyrimidines may not only complicate the interpretation of drug sensitivity tests and other in vitro studies but also adversely affect treatment in vivo. Previously we reported that in a lymphocyte clonal assay, thymidine and hypoxanthine released from dead or damaged cells reduced methotrexate cytotoxicity. We now report that the nucleoside transport inhibitor dipyridamole (DP), at 1.0 microM, abolished 3H-thymidine uptake into PHA stimulated lymphocytes, potentiated methotrexate cytotoxicity and reversed modulation of methotrexate cytotoxicity by exogenous thymidine and hypoxanthine. Normal growth of lymphocytes at high density was unaffected by 1.0-5.0 microM dipyridamole, while growth at low densities was only slightly reduced. Hydroxy-nitrobenzylthioguanosine (555) was a less potent inhibitor of 3H-thymidine uptake and was toxic to normal lymphocytes at concentrations inhibiting 3H-thymidine uptake. Nucleoside transport inhibitors isolate the cellular effects of nucleic acid antimetabolites, and provide a tool to study mechanisms of antifolate cytotoxicity.

Full text

PDF
383

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bastida E., del Prado J., Almirall L., Jamieson G. A., Ordinas A. Inhibitory effects of dipyridamole on growth, nucleoside incorporation, and platelet-activating capability in the U87MG and SKNMC human tumor cell lines. Cancer Res. 1985 Sep;45(9):4048–4052. [PubMed] [Google Scholar]
  2. Fischer P. H., Pamukcu R., Bittner G., Willson J. K. Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole. Cancer Res. 1984 Aug;44(8):3355–3359. [PubMed] [Google Scholar]
  3. Grem J. L., Fischer P. H. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels. Cancer Res. 1986 Dec;46(12 Pt 1):6191–6199. [PubMed] [Google Scholar]
  4. Howell S. B., Mansfield S. J., Taetle R. Thymidine and hypoxanthine requirements of normal and malignant human cells for protection against methotrexate cytotoxicity. Cancer Res. 1981 Mar;41(3):945–950. [PubMed] [Google Scholar]
  5. Hughes J. M., deFazio A., Tattersall M. H. Modulation of antifolate cytotoxicity by metabolites from dying cells in a lymphocyte clonal assay. Br J Cancer. 1988 May;57(5):459–463. doi: 10.1038/bjc.1988.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mizel S. B., Wilson L. Nucleoside transport in mammalian cells. Inhibition by colchicine. Biochemistry. 1972 Jul 4;11(14):2573–2578. doi: 10.1021/bi00764a003. [DOI] [PubMed] [Google Scholar]
  7. Muggia F. M., Slowiaczek P., Tattersall M. H. Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cells. Anticancer Res. 1987 Mar-Apr;7(2):161–166. [PubMed] [Google Scholar]
  8. Paul B., Chen M. F., Paterson A. R. Inhibitors of nucleoside transport. A structure-activity study using human erythrocytes. J Med Chem. 1975 Oct;18(10):968–973. doi: 10.1021/jm00244a003. [DOI] [PubMed] [Google Scholar]
  9. Plagemann P. G., Estensen R. D. Cytochalasin B. VI. Competitive inhibition of nucleoside transport by cultured Novikoff rat hepatoma cells. J Cell Biol. 1972 Oct;55(1):179–185. doi: 10.1083/jcb.55.1.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Plagemann P. G., Wohlhueter R. M. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells. Cancer Res. 1985 Dec;45(12 Pt 1):6418–6424. [PubMed] [Google Scholar]
  11. Plagemann P. G., Wohlhueter R. M. Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine. Biochim Biophys Acta. 1984 Jun 13;773(1):39–52. doi: 10.1016/0005-2736(84)90548-0. [DOI] [PubMed] [Google Scholar]
  12. Sobrero A. F., Bertino J. R. Endogenous thymidine and hypoxanthine are a source of error in evaluating methotrexate cytotoxicity by clonogenic assays using undialyzed fetal bovine serum. Int J Cell Cloning. 1986 Jan;4(1):51–62. doi: 10.1002/stem.5530040106. [DOI] [PubMed] [Google Scholar]
  13. Sobrero A. F., Moir R. D., Bertino J. R., Handschumacher R. E. Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line. Cancer Res. 1985 Jul;45(7):3155–3160. [PubMed] [Google Scholar]
  14. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol. 1981 Apr;126(4):1614–1619. [PubMed] [Google Scholar]
  15. Tattersall M. H., Slowiaczek P., De Fazio A. Regional variation in human extracellular purine levels. J Lab Clin Med. 1983 Sep;102(3):411–420. [PubMed] [Google Scholar]
  16. Taylor I. W., Tattersall M. H. Methotrexate cytotoxicity in cultured human leukemic cells studied by flow cytometry. Cancer Res. 1981 Apr;41(4):1549–1558. [PubMed] [Google Scholar]
  17. Van Mouwerik T. J., Pangallo C. A., Willson J. K., Fischer P. H. Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole. Biochem Pharmacol. 1987 Mar 15;36(6):809–814. doi: 10.1016/0006-2952(87)90168-7. [DOI] [PubMed] [Google Scholar]
  18. Wadler S., Subar M., Green M. D., Wiernik P. H., Muggia F. M. Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma. Cancer Treat Rep. 1987 Sep;71(9):821–824. [PubMed] [Google Scholar]
  19. Weber G. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res. 1983 Aug;43(8):3466–3492. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES